AtriCure, Inc. (ATRC) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $59.54 +0.71%
Revenue Growth %: +12.6%
Financial Fact:
Cost of revenue: 10.87M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +12.6%
Financial Fact:
Cost of revenue: 10.87M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
AtriCure, Inc. (NASDAQ: ATRC) reported Q2 EPS of ($0.10), $0.09 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $26.5 million versus the consensus estimate of $25.03 million.
For earnings history and earnings-related data on AtriCure, Inc. (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- UBS cuts KOSPI target by nearly 10% to reflect higher rates
- Jana Partners urges Cooper Companies to replace CEO and explore asset sales
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
